Avidity Biosciences to Participate in Upcoming Investor Conferences

/PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody...

Related Keywords

Kath Gallagher ,Linkedin ,Twitter ,Company Contact ,Avidity Biosciences Inc ,Prnewswire Avidity Biosciences Inc ,Nasdaq ,Antibody Oligonucleotide Conjugates ,Fargo Healthcare Conference ,Annual Genetic Medicines Conference ,Oligonucleotide Conjugates ,Avidity Biosciences ,Nc ,